BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 13, 2018
View Archived Issues
Tac2 neuropeptide system regulates behavioral changes caused by chronic social isolation in mice
Read More
Pluristem presents topline results from phase II study of PLX-PAD cells
Read More
Results from first-in-human GAPVAC-101 trial of APVAC vaccines in newly diagnosed glioblastoma
Read More
Second-generation HIF-2-alpha inhibitor PT-2977 well tolerated in first-in-human trial
Read More
ITGB3 gene polymorphism is positively associated with pericellular fibrosis in patients with NAFLD
Read More
Novel gene therapy for the treatment of Rett syndrome demonstrates efficacy and safety in vivo
Read More
IL18-secreting CAR T cells have improved antitumor activity and promote endogenous immune responses
Read More
FDA grants rare pediatric disease designation to A-4250
Read More
BridgeBio to acquire ALXN-1101 from Alexion for MoCD type A
Read More
Alexion and Complement partner to codevelop CP-010 for neurodegenerative disorders
Read More
Cynata reports 6-month data from cohort A of phase I trial of CYP-001 in acute GvHD
Read More
Ganovo approved in China for hepatitis C
Read More
CStone initiates pivotal studies of CS-1001 in China
Read More
Bioelectron Technology presents new imidazole compounds
Read More
4D Pharma gains further clearances to conduct phase II study of Blautix for IBS
Read More
Bristol-Myers Squibb patents TYK2 inhibitors
Read More
IMPACT Therapeutics identifies WEE1hu inhibitors
Read More
FDA approves Keytruda for recurrent or metastatic cervical cancer whose tumors express PD-L1
Read More
E-Scape Bio obtains rights to S1P5 receptor agonists from AbbVie for lysosomal storage disorders
Read More
Galmed reports 1-year data from phase IIb study of Aramchol in NASH
Read More
Herantis initiates phase II study of Lymfactin for secondary lymphedema
Read More
Senhwa Biosciences and PBTC to study CX-4945 in pediatric recurrent medulloblastoma
Read More
ProQR Therapeutics enters partnership to advance development of QR-313
Read More
Japanese authorities grant priority review to lorlatinib application
Read More
FDA awards fast track designation to RGX-111 for MPS I
Read More
Recommended phase II dose established in first-in-human study of 2X-121
Read More
Tyme reports detailed data from first-in-human study and compassionate use program of SM-88
Read More
Phase II study of IMO-8400 in dermatomyositis does not meet primary endpoint
Read More
Sage announces expedited SAGE-217 development plan
Read More